In vertebrates, the glycolytic enzyme enolase (EC 4.2.1.11) is present as homodimers and heterodimers formed from three distinct subunits of identical molecular weight, a, 13, and y. We report the cloning and sequencing of a cDNA encoding the ,B subunit of murine muscle-specific enolase. The corresponding amino acid sequence shows >80% homology with the ,B subunit from chicken obtained by protein sequencing and with a and y subunits from rat and mouse deduced from cloned cDNAs. In contrast, there is no homology between the 3' untranslated regions of mouse a, /3, and y enolase mRNAs, which also differ greatly in length. 
In higher organisms the glycolytic enzyme enolase (2- phospho-D-glycerate hydro-lyase; EC 4.2.1.11) is found as homodimers and heterodimers formed from three distinct subunits of identical molecular weight, a, p, and y (1, 2) . In adult tissues, the a subunit is found in many cell types, but the y and p subunits are specifically expressed in neurons and muscle cells, respectively (2, 3) . aa enolase predominates in the early embryo. In skeletal muscle, it remains the major form until the perinatal period when a progressive switch from aa to 3/,8 enolase occurs in parallel with the maturation of muscle tissues (3, 4) . In adult skeletal muscie, p,8 enolase molecules account for almost all of the enolase activity (3) (4) (5) , and immunohistochemical analysis has shown that the p subunit is mainly located in type II fibers (6) . In contrast, significant amounts of ubiquitous aa enolase are maintained in adult cardiac and smooth muscles (3) . Expression of ,pp enolase seems to be correlated with the functional state of muscle tissue (3) and is also considered to be under neural control (3, 7) . Thus, denervation causes a decrease in the rate of synthesis of enolase and other glycolytic enzymes (7, 8) . Fetal-like patterns of muscle enolases in some neuromuscular disorders have also been reported (9) .
Consequently, studies on the molecular mechanisms that control the differential expression of a and p enolase genes should provide important data concerning the maturation of muscle cells and their functional capacity in normal and pathological adult tissues.
The amino acid sequence of p,8 enolase purified from chicken skeletal muscle has recently been elucidated (10) , confirming that the sequence has been strongly conserved. It also appears that developmental expression of the /3 subunit is correlated with levels of the corresponding translatable mRNA (11) .
Further analysis requires /3 enolase cDNA probes. We describe here the isolation of a partial-length cDNA clone for murine p enolase mRNA by cross-hybridization with a cDNA for a enolase mRNA previously cloned from mouse brain (12) . The 3 cDNA was sequenced, and both the a and 3 cDNA probes were used to analyze developmental expression of the corresponding mRNAs in vivo as well as in cultured cells.t
MATERIALS AND METHODS
Screening of a Skeletal Muscle cDNA Library from Mouse.
A cDNA library from hind thigh muscle of 12-day-old mice (13) was kindly provided by D. P. Leader (University of Glasgow). It was screened forl enolase sequences by using the nick-translated mouse a enolase 1800-base-pair (bp) cDNA insert from pBE a6 and a 250-bp fragment excised from its 325-bp 3' untranslated region (3' UTR) (12) .
Sequence Analysis. Sequencing of the cDNA insert from pBE ,B1 was performed according to Maxam and Gilbert (14) and completed by the dideoxy chain-termination method (15) using appropriate synthetic oligodeoxynucleotides as primers. Each segment of the sequence was determined at least twice on both strands. A consensus sequence was compiled and analyzed with the computer programs of Staden (16 (18) . Total RNA from cultured cells was obtained as described (19) from the following: (i) the permissive myogenic C2.7 cell line and a C2.7-derived "inducible" variant previously described (19) ; (ii) the embryonic C3H1OTY2 cell line (20) (27) .
cDNA from pBE P1 (Fig. 1 The clone containing the longest insert (1200 bp), designated pBE P1, was used for further analysis.
Sequence Analysis of P Enolase cDNA. As shown in Fig. 1 , the pBE P1 insert included the entire 78-bp 3' UTR and a 1128-bp coding region specifying 376 amino acids-i.e., about 87% of the expected length of the mouse 3 enolase subunit (5, 10, 28) . The deduced amino acid sequence showed 86% homology with the chicken muscle (3 enolase sequence between glycine 58 and lysine 433 (10), the differences in amino acids being scattered along the sequence rather than clustered in small regions. Arginine 414 and histidine 191, two residues suggested to be involved in substrate and Mg2+ binding, respectively (29) , were found at the expected position in the mouse ( sequence (Fig. 1) .
A homology of 83% at the amino acid level and of 78% at the nucleotide level was also found with the coding regions both of a and 'y enolase cDNAs from rat. In contrast, the short 3' UTR of mouse ,3 enolase cDNA showed no significant homology with the longer 3' UTR of rat a and y cDNAs (17) . Similar results were obtained by using mouse a and y enolase cDNAs for sequence comparisons (see Materials and Methods, "sequence analysis") in agreement with our colony hybridization data.
RNA Gel Blot and Southern Blot Analyses. Blot hybridization of total RNA from skeletal and cardiac muscles, using pBE (1 cDNA as a probe, revealed a single sequence of 1600 bases corresponding to mouse ( enolase mRNA. In agreement with the muscle-specific expression of P enolase subunit (3), this sequence was undetectable in brain and liver ( Fig. 2A) . It was also clearly shorter than a enolase mRNA (Fig. 3B) (Fig. 2B) . Evidence has also been obtained from Southern blot analysis and genomic cloning that a, (3, and y enolase subunits are encoded by three distinct genes (data not shown).
Developmental Expression of .8 and a Enolase mRNAs in
Skeletal Muscle. A large increase in ( enolase mRNA occurred between E20 and P60 (Fig. 3A) coinciding with muscle maturation, as indicated by the accumulation of skeletal actin transcripts (Fig. 3D ). In contrast, the level of a enolase mRNA was weakly modulated and reached a minimal value at P60 (Fig. 3C ). Although the a and , probes were of similar length and specific radioactivity, the time required to visualize ca mRNA was 6-fold longer than for ( mRNA (Fig. 3 (Fig. 3B) but not between the P probe and a mRNA (Fig. 3A) . Both of these observations suggest that during the developmental period examined, 8 enolase transcripts are considerably more abundant than a enolase transcripts.
Expression of 13 Enolase Transcripts Occurs at the Myoblast Stage. Expression of(3 enolase transcripts was investigated in permissive and inducible C2.7 myoblasts (19), in C3H1OT1/2 cells, and in the myogenic derivatives of the latter. Fig. 4 b and c show that (3 enolase mRNA was present in proliferating and quiescent myoblasts and accumulated when terminal differentiation occurred. This clearly contrasts with skeletal actin transcripts, which were detected only in differentiated cells (Fig. 4d) . As a premyogenic candidate we used C3H1OTY2 cells that can be converted into myoblasts either by treatment with DNA hypomethylating agents (T4 cells) (21, 30) or by transfection with MyoD1 cDNA (2.5 cells) (22) . Fig. 4b shows that (3 enolase transcripts were undetectable in either proliferating or quiescent C3H1OTYz cells, even after a longer exposure time (Fig. 4c) . Interestingly, ( enolase mRNA was already present in proliferative T4 and 2.5 cells (Fig. 4 b and c) . Fig. 4a shows that transcripts ofthe a enolase subunit were present in all cells examined.
Expression of (3 Enolase Transcripts Increases During Terminal Differentiation of Myoblasts. A time course of the changes in (3and a enolase, as well as a actin mRNA levels during terminal differentiation of myoblasts, is presented in Fig. 5 . For this analysis, C2.7 inducible myoblasts, which become able to differentiate only under defined culture conditions, were used (19 . Seven micrograms of each RNA was analyzed by using the same a enolase, ( enolase, and a actin probes as described for Fig. 3 A, C, and D, respectively. In each experiment exposure times of the autoradiograms were different for each mRNA; thus direct comparison between band intensities can be made only within each panel. RNA sizes are indicated in kb. Culture conditions for T4 and 2.5 cells were those described for permissive and inducible C2.7 cells (19) . Quiescent cells were collected after 7 days in growth medium, and differentiated cells were collected after 2 days (T4, 2.5, and C2.7 permissive cells) or 3 days (C2.7 inducible cells) in differentiation medium (19) . Since the 2.5 clone had a slower growth rate, proliferating cells were collected 5 days after plating with one change of medium on day 3. Biochemistry: Lamande' et al. mRNA levels in the same experiment is presented in Fig. 5 Inset. The ratio of to a mRNA levels increased 4-fold, indicating that the 83 enolase transcript is preferentially accumulated during terminal differentiation of myoblasts.
DISCUSSION
We report here the cloning and sequencing of a cDNA encoding the subunit of mouse muscle-specific enolase. We showed that the transition from aa to (3, 8 (31, 32) a and 'y subunits. In contrast, no homology was found between the 78-bp 3' UTR of (8 enolase mRNA and the 3' UTR of mouse a and 'y mRNAs, which are about 4-and 10-fold longer, respectively, and heterologous themselves. It remains unknown whether the different lengths and sequences of the 3' UTR in mouse a, (3, and 'y mRNAs are related to the specificity of their cellular expression. It is interesting to note in this respect that the length and sequence of the 3' UTR of neuron-specific 'y mRNA are highly conserved between rat and human species (32) .
Postnatal development of rat and mouse skeletal muscle is accompanied by a large increase in total enolase activity due to the specific accumulation of .8f3 enolase, whereas the aa isoform decreases to a negligible level (3, 4) . In adult rat skeletal muscle about 96% of all enolase molecules was found to be (,3( dimers (3) . The modulations of a and (3 enolase mRNA levels observed in developing mouse thigh muscle are consistent with these data. At birth, both a and ( enolase transcripts are expressed. Thereafter (3 mRNA level increases greatly up to the adult stage while a mRNA becomes barely detectable. Changes in the levels of both mRNAs appear, therefore, to be involved in the regulation of the transition from aa to muscle-specific 3,8 enolase. Further studies are required to determine whether the regulation of enolase subunit levels in developing muscle operates at the transcriptional level.
The use of myogenic cells in culture permitted examination of the expression of enolase mRNAs during the initial steps of muscle fiber formation. An increase in ,8 enolase transcript level accompanied terminal differentiation and paralleled the expression of other markers of myogenesis in culture (19, 33) such as a actin examined here. The increase in the ratio of 3 to a enolase mRNA levels indicates that the developmental transition to the adult pattern of enolase isozymes coincides with myotube formation. It appears from our study that C2.7 inducible and permissive cells already express a low but significant amount of 83 enolase transcripts at the myoblast stage. This cannot be due to leakage from the cell system since at the same time accumulation of skeletal actin transcript was not detected. This is particularly true in the case of inducible myoblasts that can be totally prevented from terminally differentiating (19) . In these cells, none of the myogenic markers analyzed so far (cholinergic receptor, skeletal and cardiac actin, and myosin light chains) is detectable at the myoblast stage (19) .
An immunohistochemical study has recently shown that proliferating myoblasts do have a particular biochemical phenotype defined at present only by the expression of desmin in the case of mouse myoblasts (34) . These data suggest that this phenotype depends on regulatory events occurring prior to the onset of terminal differentiation. The early expression of (3 enolase transcripts represents a new biochemical trait of replicating myogenic cells.
The cells of embryonic C3H1OTY2 line can be experimentally converted into myoblasts, chondroblasts, and adipoblasts (21) . In this regard it can be considered as a model system for experimental analysis of myogenic lineage determination and differentiation. Interestingly, it appears from our data that (3 enolase transcripts are undetectable in dividing and quiescent C3H1OT1/2 cells. However, proliferative myogenic T4 cells derived from C3H1OT1/2 cells treated with 5-azacytidine do contain (3 enolase transcripts as does the 2.5 clone derived from the same cells transfected with MyoD1 cDNA. It has been shown (22, 35) that the MyoD1 gene is part of a regulatory gene pathway that controls the determination and differentiation of myogenic lineages. The fact that C3H1OTY2 cells converted into myoblasts by transfection with MyoD1 gene express (3 enolase transcripts shows that (3 gene expression, in culture, occurs during early stages in the myogenic pathway and supports the notion that it could be a marker event of myogenic lineage determination in vivo. However it must be pointed out that C3H1OTY2 cells may represent an especially permissive environment for the effect of the MyoD1 gene that does not reflect the complexity of myogenic determination in the embryo.
Further in vivo and in vitro studies are required for a critical evaluation of the specificity of the early appearance of (3 enolase transcripts in the myogenic lineage. It is noteworthy, in this respect, that low levels of (3(3 enolase molecules have been found in some adult cartilaginous tissues (3).
In any cases /3,1 enolase will be a particularly interesting tool for studying the early stages in the expression of the myogenic program.
Note. Since submission of this manuscript the cloning of rat musclespecific enolase has been reported (36) .
